Anfarma

Anfarma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €333,952 and a net result of €45,663. Equity is growing by about 5.3% per year across the filed financial years. Its solvency ranks better than 92% of 22,195 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).